Literature DB >> 21836023

Dietary vitamin D and vitamin D receptor level modulate epithelial cell proliferation and apoptosis in the prostate.

Pavlo L Kovalenko1, Zhentao Zhang, Jun-Ge Yu, Yan Li, Steven K Clinton, James C Fleet.   

Abstract

Low vitamin D (VD) status may increase prostate cancer risk but experimental evidence for this relationship is modest. We tested whether low VD status or VD receptor (VDR) deletion influences prostate epithelial cell (PEC) biology using intact mice, castrated mice, or castrated mice treated with testosterone propionate (TP, 2.5 mg/kg BW). PEC proliferation (Ki-67 staining) and apoptosis (TUNEL method) were determined in the anterior prostate (AP). In study 1, wild-type (WT) and TgAPT(121) mice (a model of prostate intraepithelial neoplasia) were fed diets with 25, 200 (reference diet), or 10,000 IU VD/kg diet (as vitamin D(3)) prior to castration/repletion. Serum 25 hydroxyvitamin D levels were 26, 78, and 237 nmol/L in the three diet groups, respectively. Castration reduced proliferation and increased apoptosis in the AP while TP reversed these effects. Low VD diet increased proliferation in WT (+82%) and TgAPT(121) (+24%) mice while it suppressed apoptosis in WT (-29%) and TgAPT(121) (-37%) mice. This diet also increased the severity of prostate intraepithelial neoplastic lesions in the AP of intact TgAPT(121) mice. In study 2, mice with PEC-specific VDR deletion (PEC VDR KO) were examined after castration/repletion. TUNEL staining was 60% lower in castrated PEC VDR KO mice compared with castrated WT mice. In castrated mice given TP, Ki-67 staining was 2-fold higher in PEC VDR KO compared with WT mice. Our data show that low diet VDR or VDR deletion provide a prostate environment that is permissive to early procarcinogenic events that enhance prostate cancer risk.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21836023      PMCID: PMC3188351          DOI: 10.1158/1940-6207.CAPR-11-0035

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  49 in total

Review 1.  Chemoprevention: an essential approach to controlling cancer.

Authors:  Michael B Sporn; Nanjoo Suh
Journal:  Nat Rev Cancer       Date:  2002-07       Impact factor: 60.716

2.  Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation.

Authors:  X Wu; J Wu; J Huang; W C Powell; J Zhang; R J Matusik; F O Sangiorgi; R E Maxson; H M Sucov; P Roy-Burman
Journal:  Mech Dev       Date:  2001-03       Impact factor: 1.882

3.  1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms.

Authors:  X Y Zhao; D M Peehl; N M Navone; D Feldman
Journal:  Endocrinology       Date:  2000-07       Impact factor: 4.736

4.  Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2.

Authors:  S E Blutt; T J McDonnell; T C Polek; N L Weigel
Journal:  Endocrinology       Date:  2000-01       Impact factor: 4.736

5.  Insulin-like growth factor binding protein-3 mediates 1 alpha,25-dihydroxyvitamin d(3) growth inhibition in the LNCaP prostate cancer cell line through p21/WAF1.

Authors:  B J Boyle; X Y Zhao; P Cohen; D Feldman
Journal:  J Urol       Date:  2001-04       Impact factor: 7.450

6.  Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage.

Authors:  E Kallay; P Pietschmann; S Toyokuni; E Bajna; P Hahn; K Mazzucco; C Bieglmayer; S Kato; H S Cross
Journal:  Carcinogenesis       Date:  2001-09       Impact factor: 4.944

7.  Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland).

Authors:  M H Ahonen; L Tenkanen; L Teppo; M Hakama; P Tuohimaa
Journal:  Cancer Causes Control       Date:  2000-10       Impact factor: 2.506

8.  Vitamin D receptor-dependent antitumour effects of 1,25-dihydroxyvitamin D3 and two synthetic analogues in three in vivo models of prostate cancer.

Authors:  G M Oades; K Dredge; R S Kirby; K W Colston
Journal:  BJU Int       Date:  2002-10       Impact factor: 5.588

Review 9.  A systematic review and meta-analysis of bone metabolism in prostate adenocarcinoma.

Authors:  Ary Serpa Neto; Marcos Tobias-Machado; Marcos A P Esteves; Marília D Senra; Marcelo L Wroclawski; Fernando L A Fonseca; Rodolfo B dos Reis; Antônio C L Pompeo; Auro Del Giglio
Journal:  BMC Urol       Date:  2010-05-19       Impact factor: 2.264

10.  Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling.

Authors:  H G Pálmer; J M González-Sancho; J Espada; M T Berciano; I Puig; J Baulida; M Quintanilla; A Cano; A G de Herreros; M Lafarga; A Muñoz
Journal:  J Cell Biol       Date:  2001-07-23       Impact factor: 10.539

View more
  25 in total

Review 1.  Vitamin D and cancer: a review of molecular mechanisms.

Authors:  James C Fleet; Marsha DeSmet; Robert Johnson; Yan Li
Journal:  Biochem J       Date:  2012-01-01       Impact factor: 3.857

2.  Schlafen 12 expression modulates prostate cancer cell differentiation.

Authors:  Pavlo L Kovalenko; Marc D Basson
Journal:  J Surg Res       Date:  2014-03-27       Impact factor: 2.192

3.  Modeling vitamin D insufficiency and moderate deficiency in adult mice via dietary cholecalciferol restriction.

Authors:  Sanjay M Mallya; Kristin R Corrado; Elizabeth A Saria; Feng-Ning Frank Yuan; Huy Q Tran; Kirsten Saucier; Elisa Atti; Sotirios Tetradis; Andrew Arnold
Journal:  Endocr Res       Date:  2016-02-23       Impact factor: 1.720

4.  Vitamin D Signaling Suppresses Early Prostate Carcinogenesis in TgAPT121 Mice.

Authors:  James C Fleet; Pavlo L Kovalenko; Yan Li; Justin Smolinski; Colleen Spees; Jun-Ge Yu; Jennifer M Thomas-Ahner; Min Cui; Antonio Neme; Carsten Carlberg; Steven K Clinton
Journal:  Cancer Prev Res (Phila)       Date:  2019-04-26

5.  The prostate cancer TMPRSS2:ERG fusion synergizes with the vitamin D receptor (VDR) to induce CYP24A1 expression-limiting VDR signaling.

Authors:  Jung-Sun Kim; Justin M Roberts; William E Bingman; Longjiang Shao; Jianghua Wang; Michael M Ittmann; Nancy L Weigel
Journal:  Endocrinology       Date:  2014-06-13       Impact factor: 4.736

6.  Response of Vitamin D Concentration to Vitamin D3 Administration in Older Adults without Sun Exposure: A Randomized Double-Blind Trial.

Authors:  Janice B Schwartz; Lynn Kane; Daniel Bikle
Journal:  J Am Geriatr Soc       Date:  2016-01       Impact factor: 5.562

7.  Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance.

Authors:  David T Marshall; Stephen J Savage; Elizabeth Garrett-Mayer; Thomas E Keane; Bruce W Hollis; Ronald L Horst; Linda H Ambrose; Mark S Kindy; Sebastiano Gattoni-Celli
Journal:  J Clin Endocrinol Metab       Date:  2012-04-16       Impact factor: 5.958

8.  Combination of oral vitamin D3 with photodynamic therapy enhances tumor cell death in a murine model of cutaneous squamous cell carcinoma.

Authors:  Sanjay Anand; Kishore R Rollakanti; Ronald L Horst; Tayyaba Hasan; Edward V Maytin
Journal:  Photochem Photobiol       Date:  2014-05-26       Impact factor: 3.421

9.  Compensatory Changes in Calcium Metabolism Accompany the Loss of Vitamin D Receptor (VDR) From the Distal Intestine and Kidney of Mice.

Authors:  Perla C Reyes-Fernandez; James C Fleet
Journal:  J Bone Miner Res       Date:  2015-08-20       Impact factor: 6.741

10.  Loss of MLK3 signaling impedes ulcer healing by modulating MAPK signaling in mouse intestinal mucosa.

Authors:  Pavlo L Kovalenko; Lyudmyla Kunovska; Jian Chen; Kathleen A Gallo; Marc D Basson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-08-23       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.